BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $837K of BioMarin Pharmaceutical Inc.
Sold$836,600
$83.66Price
10,000Shares
−2%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Thu, Apr 14. Filed Mon, Apr 18, 9:46 PM ET, after the close. Not investment advice.